Superior Group Reports Mixed Q2 2026: Revenue Up but Net Income Dips

  • Q2 2026 net sales rose to $147.8M, up from $144.0M in the prior year.
  • Net income fell to $1.2M (including a $2M non-cash tradename impairment charge) from $1.6M in Q2 2025.
  • Adjusted EBITDA increased to $7.7M, up from $6.1M in the prior year quarter.
  • Board approved a $0.14 per share quarterly dividend, payable August 28, 2026.
  • Full-year outlook confirmed: net sales projected between $572M and $585M.

Superior Group's Q2 2026 results highlight a mixed performance with revenue growth offset by a non-cash impairment charge in Healthcare Apparel. The company's diversified business model, including strong Branded Products performance, positions it to navigate soft market conditions. Strategic acquisitions and a healthy balance sheet remain key drivers for continued growth and shareholder value.

Segment Performance
How the Branded Products segment's strong performance will offset Healthcare Apparel's impairment challenges.
Market Conditions
Whether Superior Group can sustain growth amid soft market conditions and global economic uncertainties.
Execution Risk
The pace at which the company can integrate acquisitions and manage its expanding operations effectively.